Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Trading Update

19 Jan 2021 07:00

RNS Number : 0930M
Crossword Cybersecurity PLC
19 January 2021
 

Crossword Cybersecurity Plc

Trading Update

 

19 January 2021 - London, UK - Crossword Cybersecurity Plc (AIM:CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focused on cyber security and risk management, is pleased to announce that it expects to report results for the Financial Year ended 31 December 2020, in line with market expectations, in April 2021.

 

Overall revenue during the year is expected to show an increase of 25% to £1.6m. Within that, revenues from product and consulting revenue are anticipated to have expanded by 39%, reflecting the Company's shift from software development services to its core of product and consulting revenue. Cash balances as at 31 December were £958k.

 

Software and process development continued during 2020 with the launch of Rizikon Pro in July 2020. Rizikon Pro is an out-of-the-box, online SaaS solution, offered on a pay-as-you-go basis, giving smaller and medium sized organisations access to a set of core easy-to-use supplier assurance platform features, at a lower cost. Modules can be chosen according to need, meaning customers only pay for the features they use, and can be expanded as required. Rizikon Pro is transforming the sales model with a much shorter sales cycle and impressively high conversion from trials to paying clients.

 

Crossword continues to have several large bids in its pipeline. There were two multi-million-pound opportunities which we alluded to in an RNS on 28 September 2020 for which the process concluded in 2020; one where we received notice that procurement had been abandoned by the UK Government department, and the other where we were unsuccessful.

 

In November 2020, Crossword began working with Verifiable Credentials Ltd on its Innovate UK funded-project to allow NHS laboratories to issue Covid-19 immunity certificates. In addition, in December 2020, Crossword was awarded an Innovate UK grant with a university partner and two well-known British Manufacturing businesses, to investigate the issues around effective Manufacturing Supply Chain risk management and possible solutions.

 

In 2020, the consulting division continued to grow in a range of high-profile sectors including legal, insurance and financial services. Work commenced on a major project for one of the world's largest, global S&P500 insurance brokers.

 

Tom Ilube, CEO of Crossword, commented;

"Crossword emerged from a challenging 2020 in great shape, meeting market expectations of 25% revenue growth. We are looking forward to an exciting year ahead, accelerating roll out of Rizikon Pro, securing major consulting clients, adding to our cyber security product portfolio, and expanding internationally. We expect the revenue growth rate to more than double in 2021."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK Market Abuse Regulation. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Contacts

Crossword Cybersecurity plc - Tel: +44 (0) 20 3953 8460

Email: info@crosswordcybersecurity.com

Tom Ilube, Chief Executive Officer

Mary Dowd, Finance Director

 

Grant Thornton (Nominated Adviser) - Tel: +44 (0) 20 7383 5100

Colin Aaronson / Jamie Barklem

 

Hybridan LLP (Broker) - Tel: +44 (0)203 764 2341

Claire Louise Noyce

 

For media enquiries contact:

Duncan Gurney, GingerPR

duncan@gingerpr.co.uk - Tel: +44 (0)1932 485 300

 

About Crossword Cybersecurity plc

Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security and risk management related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's leading product, is a SaaS platform that enables medium to large companies to assess and manage all risks from their suppliers. Nixer CyberML, Crossword's most recently launched product, is a new tool for businesses that want to solve advanced security and cybercrime problems, such as detecting and dealing with compromised accounts, fraud, and in-application denial of service attacks. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSFAAEFSEIF
Date   Source Headline
18th Mar 20103:44 pmRNSBoard Changes
19th Feb 20107:00 amRNSMulti Million Pound Contract Win
8th Feb 20107:00 amRNSMajor Contract Win
26th Jan 20104:33 pmRNSResignation of Director and Trading Update
23rd Nov 20097:00 amRNSInterim Results
10th Nov 200911:30 amRNSNotice of Interim Results' Date
20th Oct 200911:35 amRNSHolding(s) in Company
15th Oct 200911:03 amRNSResult of General Meeting
29th Sep 20097:00 amRNSPosting of Circular
28th Sep 20097:00 amRNSSuccessful Placing & Trading Update
21st Sep 20094:59 pmRNSHolding(s) in Company
24th Aug 20099:45 amRNSBoard Changes
24th Jul 20095:28 pmRNSResult of AGM
22nd Jun 20097:00 amRNSFinal Results
15th Jun 200911:14 amRNSHolding(s) in Company
22nd Apr 20097:01 amRNSNew CFO Appointed
22nd Apr 20097:00 amRNSDirector's Shareholding
21st Apr 20097:00 amRNSPre-Close Trading Update
15th Apr 20097:00 amRNSSignificant Hotel Contract Win
23rd Mar 20093:59 pmRNSDirector/PDMR Shareholding
16th Feb 20097:00 amRNSSignificant European Contract Win
23rd Jan 200912:43 pmRNSDirector/PDMR Shareholding
30th Dec 20087:00 amRNSContract Win
18th Dec 20087:00 amRNSSignificant US Contract Win
20th Nov 20087:00 amRNSInterim Results
27th Oct 20083:16 pmRNSHolding(s) in Company
24th Oct 20087:00 amRNSNew Board Appointment
18th Sep 20082:16 pmRNSResult of AGM
20th Aug 20089:14 amRNSAnnual Report and Financial Statements
15th Aug 20087:00 amRNSMATRA performing strongly - earn-out terms agreed
11th Aug 200810:29 amRNSDirector/PDMR Shareholding
6th Aug 20082:31 pmRNSHolding(s) in Company
1st Aug 20082:44 pmRNSHolding(s) in Company
24th Jul 20087:00 amRNSFinal Results
23rd Jul 20082:57 pmRNSHolding(s) in Company
15th Jul 20087:00 amRNSSignificant Contract Win
4th Jul 20087:00 amRNSContract Win
1st Jul 20087:31 amRNSDisposal
14th May 20089:36 amRNSChange of Adviser
2nd May 200812:20 pmRNSDisposal of Cyntergy
7th Apr 20081:04 pmRNSStrategic Review
7th Mar 200811:28 amRNSHolding(s) in Company Amend
6th Mar 20084:57 pmRNSHolding(s) in Company
6th Mar 20084:56 pmRNSHolding(s) in Company
28th Feb 20083:22 pmRNSEGM Statement
5th Feb 200811:54 amRNSPlacing and Open Offer
1st Feb 20081:11 pmRNSWorking capital drawdown
16th Jan 200811:22 amRNSDirectorate Change
31st Dec 200712:55 pmRNSInterim Results
24th Dec 200711:25 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.